BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Free fatty acid receptor 2 (FFAR2; GPR43); FFAR3 (GPR41)

February 5, 2015 8:00 AM UTC

Cell culture and mouse studies suggest FFAR2 and FFAR3 antagonists could help treat type 2 diabetes. In mouse and human β cell lines, agonizing FFAR2 and FFAR3 with acetate decreased insulin secretion...